● Recruiting

Intra-articular Allocetra in Osteoarthritis of the of the Temporomandibular Joint (TMJ)

Condition: Temporomandibular Joint Osteoarthritis · Sponsor: Dr. Amit Druyan

PhasePhase 1

Planned participants6

Who can joinAll sexes, 18 Years to 60 Years

Healthy volunteersNo

About this study

This study is a single center trial to assess the safety and initial efficacy of intra-articular administration of Allocetra to patients with Temporomandibular Joint Osteoarthritis (TMJ-OA)

This description comes directly from the study's public registry record.

Talk to the study team

Amit Druyan, Dr. · 972-3-5304413 · Amit.Druyan@sheba.health.gov.il

Tehila Biton · 972-3-5304413 · tehila.biton@sheba.health.gov.il

Always discuss trial participation with your own doctor first.

Locations (1)

Sheba Medical Center

Ramat Gan, Israel

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06748651